Daily non-political popular news in brief.

Northwestern Memorial trial may wean kidney transplant patients off antirejection drugs

After transplant surgery, antirejection drugs for the organ recipient are a must. But prolonged use can have serious side effects, including infections, heart disease and even cancer. A team of researchers at Northwestern University's Feinberg School of Medicine is working with Northwestern Memorial Hospital's department of organ transplantation in a new study that seeks to eliminate the need for antirejection drugs by transplanting stem cells from a kidney donor's bone marrow into the organ recipient.

Read more »

Keywords: northwestern, memorial, trial, wean, kidney, transplant, patients, antirejection, drugs, patient, drug

« Previous | Next »

Similar news on "Northwestern Memorial trial may wean kidney transplant patients off antirejection drugs":

1. Antibody reduces incidence of acute rejection in high-risk kidney transplant patients
   11-08-2006 · EurekAlert!
   Nearly 70 percent of kidney transplant patients get short-term drug therapy initially administered during surgery to help prevent rejection. In the first direct comparison of the two drugs most commonly given to ward off acute kidney rejection, an international study led by Washington University School of Medicine in St. Louis shows that one -- anti-thymocyte globulin -- is superior. The results also suggest the drug could potentially save millions of dollars in health care costs.
   Similar news · Read more »
   
2. Patients can't recall their medications to tell doctors
   10-11-2007 · EurekAlert!
   Doctors depend on patients to accurately tell them what drugs they are taking in out-patient visits. But Northwestern University found nearly 50 percent of patients taking antihypertensive drugs were unable to accurately name a single one of their medications. Thus, doctors can't monitor if a drug is working or know about potential adverse interactions.
   Similar news · Read more »
   
3. Experimental procedure induces tolerance to mismatched kidney transplants
   01-23-2008 · EurekAlert!
   Four of five patients participating in a trial of an experimental protocol designed to induce immune tolerance to HLA-mismatched kidney transplants have been able to discontinue immunosuppressive drugs. The report in the Jan. 24 New England Journal of Medicine describes the first successful, intentional induction of tolerance across the HLA barrier in a group of transplant recipients.
   Similar news · Read more »
   
4. Study provides hope that some transplant patients could live free of anti-rejection drugs
   08-20-2007 · EurekAlert!
   People with organ transplants, resigned to a lifetime of antirejection drugs, may now have reason to hope for a respite, say researchers at Lucile Packard Children's Hospital and the Stanford University School of Medicine.
   Similar news · Read more »
   
5. Prescribing information for kidney disease far too vague
   12-06-2006 · EurekAlert!
   Prescribing information for healthcare professionals treating patients with kidney disease is too vague, concludes the latest issue of Drug and Therapeutics Bulletin (DTB). Many of the 4-5 percent of the UK population with serious chronic kidney disease are elderly people, who are often taking several different drugs. Other risk factors for the disease include diabetes and high blood pressure.
   Similar news · Read more »
   
6. Hepatitis B drug can compromise HIV treatment
   06-20-2007 · EurekAlert!
   Treating hepatitis B patients with the drug entecavir can cause those who are also infected with HIV to become resistant to two of the most important drugs in the anti-HIV arsenal. In findings published in the New England Journal of Medicine, researchers reported that a patient infected with both hepatitis B and HIV who was treated with entecavir developed a mutant strain of HIV that is resistant to the antiviral drugs lamivudine and emtricitabine.
   Similar news · Read more »
   
7. 2 drugs work better together than either alone against kidney cancer
   07-30-2007 · EurekAlert!
   A combination of two drugs works better than either drug alone for patients with renal cell carcinoma, the most common form of kidney cancer, according to a pilot study led by Duke University Comprehensive Cancer Center researchers.
   Similar news · Read more »
   
8. A drug's brand name skews patient treatment choices
   05-21-2007 · EurekAlert!
   The brand name of a drug can strongly influence treatment decisions by patients, according to a randomized trial of decision aids by researchers from McMaster University.
   Similar news · Read more »
   
9. Mouse Tests Predict Drug Response In Relapsing Pancreatic Cancer Patients
   10-12-2006 · ScienceDaily
   By slicing up bits of patient tumors and grafting them into mice, Johns Hopkins Kimmel Cancer Center specialists have figured out how to accurately 'test drive' chemotherapy drugs to learn in advance which drug treatments offer each individual pancreatic cancer patient the best therapeutic journey.
   Similar news · Read more »
   
10. Bronchial thermoplasty may allow severe asthma patients to wean off oral corticosteroids
    05-23-2007 · EurekAlert!
    Positive results from the Research in Severe Asthma (RISA) Trial of Bronchial Thermoplasty were reported today at the annual scientific assembly of the American Thoracic Society (ATS). Clinically and statistically significant improvements in pulmonary function, asthma control, and quality of life, as well as a reduction in use of rescue medications, were observed following the bronchial thermoplasty procedure in patients with severe asthma. Bronchial Thermoplasty is first non-drug treatment for asthma.
    Similar news · Read more »